83 related articles for article (PubMed ID: 24710758)
1. Application of a medium-energy collimator for I-131 imaging after ablation treatment of differentiated thyroid cancer.
Kobayashi M; Wakabayashi H; Kayano D; Konishi T; Kojima H; Yoneyama H; Okuda K; Tsushima H; Onoguchi M; Kawai K; Kinuya S
Ann Nucl Med; 2014 Jul; 28(6):551-8. PubMed ID: 24710758
[TBL] [Abstract][Full Text] [Related]
2. Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer.
Kobayashi M; Wakabayashi H; Kojima H; Konishi T; Okuda K; Yoneyama H; Kayano D; Tobisaka M; Tsushima H; Onoguchi M; Kawai K; Kinuya S
Hell J Nucl Med; 2013; 16(3):175-80. PubMed ID: 24137580
[TBL] [Abstract][Full Text] [Related]
3. A parallel-cone collimator for high-energy SPECT.
Beijst C; Elschot M; Viergever MA; de Jong HW
J Nucl Med; 2015 Mar; 56(3):476-82. PubMed ID: 25655627
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of low- and medium-energy collimators in 123I-MIBG myocardial scintigraphy].
Sakashita R; Sugimoto K; Fukuya Y; Fujibuchi H; Ishida T; Higashimura K; Tsuchida T
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2007 Feb; 63(2):241-6. PubMed ID: 17387245
[TBL] [Abstract][Full Text] [Related]
5. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
[TBL] [Abstract][Full Text] [Related]
6. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.
Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC
Clin Imaging; 2009; 33(1):49-54. PubMed ID: 19135930
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of novel whole-body high-resolution rodent SPECT (Linoview) based on direct acquisition of linogram projections.
Walrand S; Jamar F; de Jong M; Pauwels S
J Nucl Med; 2005 Nov; 46(11):1872-80. PubMed ID: 16269602
[TBL] [Abstract][Full Text] [Related]
8. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
9. Collimator selection, acquisition speed, and visual assessment of 131I-tositumomab biodistribution in a phantom model.
Tan HK; Wassenaar RW; Zeng W
J Nucl Med Technol; 2006 Dec; 34(4):224-7. PubMed ID: 17146111
[TBL] [Abstract][Full Text] [Related]
10. Appropriate collimators in a small animal SPECT scanner with CZT detector.
Higaki Y; Kobayashi M; Uehara T; Hanaoka H; Arano Y; Kawai K
Ann Nucl Med; 2013 Apr; 27(3):271-8. PubMed ID: 23288435
[TBL] [Abstract][Full Text] [Related]
11. Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies.
Macey DJ; DeNardo GL; DeNardo SJ; Hines HH
J Nucl Med; 1986 Sep; 27(9):1467-74. PubMed ID: 3489084
[TBL] [Abstract][Full Text] [Related]
12. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
[TBL] [Abstract][Full Text] [Related]
13. Performance evaluation of the eXplore speCZT preclinical imaging system.
Matsunari I; Miyazaki Y; Kobayashi M; Nishi K; Mizutani A; Kawai K; Hayashi A; Komatsu R; Yonezawa S; Kinuya S
Ann Nucl Med; 2014 Jun; 28(5):484-97. PubMed ID: 24610679
[TBL] [Abstract][Full Text] [Related]
14. A comparison of different energy window subtraction methods to correct for scatter and downscatter in I-123 SPECT imaging.
Lagerburg V; de Nijs R; Holm S; Svarer C
Nucl Med Commun; 2012 Jul; 33(7):708-18. PubMed ID: 22513883
[TBL] [Abstract][Full Text] [Related]
15. Primary, scatter, and penetration characterizations of parallel-hole and pinhole collimators for I-123 SPECT.
Könik A; Auer B; De Beenhouwer J; Kalluri K; Zeraatkar N; Furenlid LR; King MA
Phys Med Biol; 2019 Dec; 64(24):245001. PubMed ID: 31746783
[TBL] [Abstract][Full Text] [Related]
16. Assessment of collimators in radium-223 imaging with channelized Hotelling observer: a simulation study.
Takahashi A; Baba S; Sasaki M
Ann Nucl Med; 2018 Dec; 32(10):649-657. PubMed ID: 30073570
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of 99mTc-pertechnetate single-photon emission computed tomography in remnant mass estimation of postsurgical patients of differentiated thyroid cancer during internal dosimetry.
Nadig MR; Pant GS; Bal C
Nucl Med Commun; 2008 Sep; 29(9):809-14. PubMed ID: 18677209
[TBL] [Abstract][Full Text] [Related]
18. Iodine-131 imaging using 284 keV photons with a small animal CZT-SPECT system dedicated to low-medium-energy photon detection.
Kojima A; Gotoh K; Shimamoto M; Hasegawa K; Okada S
Ann Nucl Med; 2016 Feb; 30(2):169-75. PubMed ID: 26395374
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine remnant ablation in low-risk differentiated thyroid cancer.
Saengsuda Y
J Med Assoc Thai; 2013 May; 96(5):614-24. PubMed ID: 23745318
[TBL] [Abstract][Full Text] [Related]
20. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
